Kentucky’s Opioid Abatement Advisory Commission (KYOAAC) held the second of two public hearings and general information sessions regarding its plan to allocate $42 million from state funds for ibogaine research to support the treatment of addictions and to help stem opioid overdoses. 

On Friday, Sept. 15, the commission heard over two dozen military veterans, former patients, parents and family members, psychologists and other advocates for treating  Opioid Use Disorder (OUD) with the naturally-occurring psychedelics. The shared their insights and hopes, following the first hearing (on July 17) which featured scientific experts and clinicians.

See Also: Psychedelics To Treat Addiction? How Substances Like Ibogaine Are Changing The Game


Full story available on

A note to our visitors

This website has updated its privacy policy in compliance with changes to European Union data protection law, for all members globally. We’ve also updated our Privacy Policy to give you more information about your rights and responsibilities with respect to your privacy and personal information. Please read this to review the updates about which cookies we use and what information we collect on our site. By continuing to use this site, you are agreeing to our updated privacy policy.